Kalvista Pharmaceuticals
Presence
Kalvista Pharmaceuticals is one of the...
Kalvista Pharmaceuticals is a company listed under the stock ticker KALV (US).
Executives
View the org chart displaying its 12 main executives
Most searched biographies at Kalvista Pharmaceuticals
- Benjamin Palleiko, Chief Executive Officer and Director
- Pat Treanor, Director
- Edward Unkart, Director
Popular executive movements at Kalvista Pharmaceuticals
- Benjamin Palleiko, who was President, Chief Financial Officer and Chief Business Officer, is promoted to Chief Executive Officer and Director (posted on March 8 2024).
- Andrew Crockett, Chief Executive Officer and Director, has left the company (posted on March 8 2024).
- Nicole Sweeny has joined the company as Chief Commercial Officer (posted on July 26 2023).
Create your alert
to follow the executive moves at Kalvista Pharmaceuticals.
Pharmaceuticals
Kalvista Pharmaceuticals has 1,868 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Kalvista Pharmaceuticals
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | KalVista Pharmaceuticals, Inc.
- KalVista Pharmaceuticals to Present at 1st Annual H.C. Wainwright Hereditary Angioedema Conference | KalVista Pharmaceuticals, Inc.
- News Releases | KalVista Pharmaceuticals, Inc.
- News Releases | KalVista Pharmaceuticals, Inc.
- News Releases | KalVista Pharmaceuticals, Inc.
- KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results | KalVista Pharmaceuticals, Inc.
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | KalVista Pharmaceuticals, Inc.
- KalVista Pharmaceuticals Presents New Data for Sebetralstat and its Oral Factor XIIa Inhibitor Program | KalVista Pharmaceuticals, Inc.
- News Releases | KalVista Pharmaceuticals, Inc.
- News Releases | KalVista Pharmaceuticals, Inc.
- View more press releases Close
Social media about Kalvista Pharmaceuticals
- Kalvista Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Kalvista Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Benjamin Palleiko 
Call Kalvista Pharmaceuticals at +1 857...
